A detailed history of Silverarc Capital Management, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 223,845 shares of ERAS stock, worth $528,274. This represents 0.15% of its overall portfolio holdings.

Number of Shares
223,845
Holding current value
$528,274
% of portfolio
0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.67 - $2.55 $373,821 - $570,804
223,845 New
223,845 $461,000
Q4 2021

Feb 14, 2022

SELL
$12.51 - $22.75 $1.16 Million - $2.12 Million
-93,122 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$17.43 - $24.34 $1.62 Million - $2.27 Million
93,122 New
93,122 $1.98 Million

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $288M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.